FBXO5 Antikörper (AA 1-250)
-
- Target Alle FBXO5 Antikörper anzeigen
- FBXO5 (F-Box Protein 5 (FBXO5))
-
Bindungsspezifität
- AA 1-250
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser FBXO5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Aufreinigung
- Protein G affinity chromatography
- Immunogen
- A recombinant fragment (203 amino acid residues between aa 1-250) from the human protein was used as the immunogen for the EMI1 antibody.
- Klon
- EMI1-1176
- Isotyp
- IgG2a kappa
- Top Product
- Discover our top product FBXO5 Primärantikörper
-
-
- Applikationshinweise
-
Optimal dilution of the EMI1 antibody should be determined by the researcher.
1. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate buffer, pH 6.0 for 10-20 min followed by cooling at RT for 20 minutes
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 0.5-1 μg/mL,Western blot: 1-2 μg/mL,Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 minutes at RT (1),Prediluted format : incubate for 30 min at RT (2) - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.2 mg/mL
- Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store the EMI1 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
- Target
- FBXO5 (F-Box Protein 5 (FBXO5))
- Andere Bezeichnung
- EMI1 (FBXO5 Produkte)
- Synonyme
- EMI1 antikoerper, FBX5 antikoerper, Fbxo31 antikoerper, 2510044I10Rik antikoerper, C85305 antikoerper, Emi1 antikoerper, emi1 antikoerper, fc65h02 antikoerper, wu:fc65h02 antikoerper, wu:fe06e07 antikoerper, wu:fz79f03 antikoerper, zgc:136397 antikoerper, zgc:158541 antikoerper, fbx5 antikoerper, Fbxo5 antikoerper, ACYPI007854 antikoerper, fbxo5 antikoerper, F-box protein 5 antikoerper, F-box only protein 5 antikoerper, F-box protein 5 L homeolog antikoerper, F-box protein 5 S homeolog antikoerper, FBXO5 antikoerper, Fbxo5 antikoerper, fbxo5 antikoerper, fbxo5.L antikoerper, fbxo5.S antikoerper
- Hintergrund
- Early Mitotic Inhibitor-1 regulates mitosis by inhibiting the anaphase promoting complex/cyclosome (APC). It is a conserved F box protein containing a zinc-binding region essential for APC inhibition. The protein functions to promote cyclin A accumulation and S phase entry in somatic cells by inhibiting the APC complex. At the G1-S transition, EMI1 is transcriptionally induced by the E2F transcription factor. Overexpression accelerates S-phase entry and can override a G1 block caused by overexpression of Cdh1 or the E2F-inhibitor p105 retinoblastoma protein (pRb). Depleting cells of EMI1 through RNA interference prevents accumulation of cyclin A and inhibits S phase entry.
- Pathways
- Mitotic G1-G1/S Phases
-